Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates
Eravacycline (ERV) has emerged as a therapeutic option for the treatment of carbapenem-resistant pathogens. However, the advent of heteroresistance (HR) to ERV poses a challenge to these therapeutic strategies. This study aimed to investigate ERV HR prevalence among common clinical isolates and furt...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2024-03-01
|
| Ráidu: | Frontiers in Microbiology |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1332458/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|